Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Frenken

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Contributions to Nephrology|January 1, 1990
Does treatment of predialysis patients with recombinant human erythropoietin compromise renal function?R A Koene, L A Frenken
Contributions to Nephrology|January 1, 1991
Renal function of pre-dialysis patients during treatment with recombinant human erythropoietinR A Koene, L A Frenken
Nederlands Tijdschrift Voor Geneeskunde|February 2, 1991
[The use of erythropoietin]L A Frenken, R A Koene
Nederlands Tijdschrift Voor Geneeskunde|March 5, 1988
[Recombinant human erythropoietin]L A Frenken, R A Koene
Kidney International. Supplement|October 1, 1992
Role of rHuEPO in treatment of uremic anemia prior to end-stage renal diseaseR A Koene, L A Frenken
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Starting r-HuEPO in chronic renal failure: when, why, and how?R A Koene, L A Frenken
The Netherlands Journal of Medicine|June 1, 1993
Erythropoietin: mechanisms of action and indications for treatmentG Vreugdenhil, L A Frenken, R A Koene
Transplantation|April 1, 1991
The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferationL A Frenken, R A Koene, W J Tax
Clinical Chemistry|June 1, 1987
Enzymatic method for determination of inulinC P Degenaar, L A Frenken, J P von Hooff
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1989
Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patientsL A Frenken, R Verberckmoes, P Michielsen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Contributions to Nephrology|January 1, 1990
Does treatment of predialysis patients with recombinant human erythropoietin compromise renal function?R A Koene, L A Frenken
Contributions to Nephrology|January 1, 1991
Renal function of pre-dialysis patients during treatment with recombinant human erythropoietinR A Koene, L A Frenken
Nederlands Tijdschrift Voor Geneeskunde|February 2, 1991
[The use of erythropoietin]L A Frenken, R A Koene
Nederlands Tijdschrift Voor Geneeskunde|March 5, 1988
[Recombinant human erythropoietin]L A Frenken, R A Koene
Kidney International. Supplement|October 1, 1992
Role of rHuEPO in treatment of uremic anemia prior to end-stage renal diseaseR A Koene, L A Frenken
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Starting r-HuEPO in chronic renal failure: when, why, and how?R A Koene, L A Frenken
The Netherlands Journal of Medicine|June 1, 1993
Erythropoietin: mechanisms of action and indications for treatmentG Vreugdenhil, L A Frenken, R A Koene
Transplantation|April 1, 1991
The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferationL A Frenken, R A Koene, W J Tax
Clinical Chemistry|June 1, 1987
Enzymatic method for determination of inulinC P Degenaar, L A Frenken, J P von Hooff
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1989
Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patientsL A Frenken, R Verberckmoes, P Michielsen, et al.
Pageof 3